The India oncology NGS market was valued at USD 23.2 million in 2022 and is projected to grow at a CAGR of 17.4% from 2023 to 2030. The adoption of cloud-based solutions in clinical research institutions, hospitals, and biotech firms is expected to simplify the management of extensive NGS-generated data. Additionally, efforts to develop a comprehensive genomic database for the Indian...